CLASS II Device recall · Reported 19 May 2021 · FDA Enforcement Report

Bile Esculin Azide Agar w/ 6mcg/ml Vancomycin recalled by Remel

Remel is recalling Bile Esculin Azide Agar w/ 6mcg/ml Vancomycin, Product #R01186, 10/package, distributed nationwide in the US. The recall was initiated on 22 Apr 2021 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #248035, Exp. 2021-04-27
Quantity recalled91/10-test units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1561-2021
FDA event ID
87830
Recalling firm
Remel, Lenexa, KS
Classification
Class II
Status
Terminated
Recall initiated
22 Apr 2021
FDA classified
12 May 2021
Reported
19 May 2021
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Packaging Defects

Timeline

22 Apr 2021Recall initiated by company
12 May 2021Classified by FDA+20 days
19 May 2021Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The media allows growth of E. faecalis ATCC 29212 with blackening of the media.

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

Remel Bile Esculin Azide Agar w/ 6mcg/ml Vancomycin, Product #R01186, 10/package - Product Usage: use in qualitative procedures as a screening method for primary isolation and presumptive identification of vancomycin-resistance enterococci (VRE) from surveillance cultures.

Where it was distributed

US Nationwide distribution in the states of AZ, CA, CO, CT, GA, IA, IL, IN, MA, MI, MN, MO, NC, ND, OH, OR, PA, SD, TN, TX, and VA. There was government distribution and no military or foreign distribution.

Nationwide ArizonaCaliforniaColoradoConnecticutGeorgiaIowaIllinoisIndianaMassachusettsMichiganMinnesotaMissouriNorth CarolinaNorth DakotaOhioOregonPennsylvaniaSouth DakotaTennesseeTexas

Questions about this recall

Why was it recalled?

The media allows growth of E. faecalis ATCC 29212 with blackening of the media.

Which lots are affected?

Lot #248035, Exp. 2021-04-27

Where was it sold?

US Nationwide distribution in the states of AZ, CA, CO, CT, GA, IA, IL, IN, MA, MI, MN, MO, NC, ND, OH, OR, PA, SD, TN, TX, and VA. There was government distribution and no military or foreign distribution.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Remel

All 86
ReportedClassRecallCompanyReasonWhere
DeviceCLASS IIGC Agar Base R04030 recalled by RemelRemelOtherNationwide
DeviceCLASS IIYeastone Broth, 10/BOX YY3462 recalled by RemelRemelOtherNationwide
DeviceCLASS IICampy CVA Medium, R01272 recalled by RemelRemelOther Bacterial ContaminationNationwide
DeviceCLASS IICamhb W/lhb, Manual, 10/box Ycp112-10 Brucella Broth, 10/box Yt3450 recalledRemelOtherNationwide
DeviceCLASS IIBlood/EMB, Levine, Product Number R02041 recalled by RemelRemelListeriaNationwide

Other Other Medical Devices recalls

All 13,884